https://www.avient.com/resources/safety-data-sheets?page=4630
ROSE SC 3
HC-6699 DARK BROWN 1 (RECT)
HMF RED UV PE 4
https://www.avient.com/resources/safety-data-sheets?page=4564
RUGGED 1
RUGGED 4 HD6706-17
GOLD METALLIC 3
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Page 3
Strategy and Execution Drive Results
90%
$22
$24
PolyOne
Stock Price
50%
$18
$20
$22
S&P 500 (relative performance)
30%
$12
$14
$16
S&P 500 (relative performance)
‐10%
10%
$6
$8
$10
50%
‐30%
$0
$2
$4
$
|
‐50%$0
2006 2007 2008 2009 2010 2011 2012 2013
Page 4
Four Pillar Strategy
The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Page 5
Spartech – Compelling Strategic Rationale
• Spartech expands PolyOne’s specialty portfolio with adjacent
technologies in attractive end markets
Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only
6% of Spartech’s revenues are outside of North America
• PolyOne has a proven management team with a track record of
transformational success
• Preliminary synergy estimated at $65 million run rate by end of
3year 3
Significant opportunity to expand profitability by leveraging
PolyOne’s four pillar strategy
• Substantial potential share price appreciation for all
shareholders
f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once
synergies realized
Page 6
Mix Shift Highlights Specialty Transformation
Old
PolyOne Transformation
100%
2015
Target
80%
In
co
m
e*
65 – 75%40%
60%
f O
pe
ra
tin
g
34% 43% 45%
65 75%
20%
o
f
2%0%
2005 2008 2010 2012 2015
Specialty OI $5M $46M $87M $114M Target
*Operating Income excludes corporate charges and special items
JV's PP&S Distribution Specialty
Page 7
Proof of Performance
2007 2012 2015
“Where we were” “Where we are” “Where we Where we were Where we are expect to be"
1) Operating Income %
Specialty 3.2% 9.1% 12 – 16%
PP&S 6.1% 9.0% 9 – 12%
Distribution 3.0% 6.4% 6 – 7.5%
2) Specialty Platform
sss% of Operating Income 20% 45% 65 – 75%
3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15%
4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit
Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
**4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS
Page 8
Proof of Performance
Spartech Opportunity
Intermediate
PolyOne Spartech Opportunity
2006 2012 Today Goal
“Where we
were”
“Where we
are”
“Where
Spartech is”*
“Where we
can go”were are Spartech is can go
Specialty
Operating
Margin
1.5% 9.1% 2.2% 8.0% – 10.0%
Margin
Page 9
*Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012
PolyOne
14%
Latin
America
3% Distribution
2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion*
United
States
14% 5%
PP&S
20%Specialty
57%
Building & HealthCare
1.02
1.20
$1.20
$1.40
ha
re
End Markets* EPS Growth
Construction
14%
17%
Industrial
9%
0.27 0 21
0.79
$0.40
$0.60
$0.80
$1.00
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
Electrical &
0.12
0.21 0.13
$0.00
$0.20
2006 2007 2008 2009 2010 2011 2012
Page 10
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Specialty
U it d
2012 Revenues: $2.4 Billion* Solutions
United
States
59%
9%
Latin
America
Building &
C t ti
HealthCare
o
f S
al
es
12-16%
End Markets* Expanding Profits
Construction
Electrical &
Industrial
15%
1.5%
3.2% 4.3%
5.3%
8.4% 9.1%
O
pe
ra
tin
g
In
co
m
e
Page 11
2006 2007 2008 2009 2010 2011 2012 2015
O
Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Designed Structures and Solutions
United States
2012 Revenues: $0.85 Billion* Solutions
84%
Latin America
4% Building & Construction
Sign & Advertising
3%
Recreation & Leisure
Pool & Spa
1%
Distribution &
Thermoform
2% Operating Income % of Sales
2012 Revenue by Industry Segment* Expanding Profits**
Electrical & Electronics
23%Industrial
3%
2.2%
8 ‐ 10%
1%
HealthCare
2012 2015
Target
Page 12
*Pro Forma includes FY2012 results for Spartech (11/03/12 YE)
**Pro Forma results include Spartech corporate allocations for FY12
Positioned for Earnings Growth
2015 Target
Rev: $5B
Adj.
EPS: $2.50
Assumptions
• High single digit organic
revenue CAGR
• Operating margins in mid range
of 2015 targets
• No global recession• No global recession
• No investment in incremental
PP&S capacity
• Completion of 2‐3 midsize
accretive acquisitions
• No divestitures
• Housing starts at 85% of 50 year
norm by 2015
R i f t bl b l 3X N t
2012
$ • Remain comfortably below 3X Net
Debt / EBITDA
Page 13
Rev: $3.0B
Adj.
EPS: $1.20
Proforma Debt Maturities & Liquidity Summary – 12/31/12
(Reflecting Financing & Spartech Acquisition)
• Total Debt at 12/31/12
h
$1,010
$297
$360 $300
$400
Debt Maturities
As of December 31, 2012
($ millions)
Less: Cash
Net Debt
213
$797
$50
$297
$100
$200
• Available Liquidity
Cash $213
$800 Debt Maturities
As of December 31, 2012
P f f 2/13 Fi i
$50 $0
2015 2017 2020
Interest Rates: 7.500% 5.000% 7.375%
Cash
ABL Availability
Total Liquidity
$213
271
$484
$600
$400
$600
Proforma for 2/13 Financing
($ millions)
Total Liquidity
• Net Debt / EBITDA = 2.0x*
$484
$50
$360
$0
$200
• Net Debt / EBITDA = 2.35x**
$50$0
2015 2020 2023
Page 14
Interest Rates: 7.500% 7.375% 5.250%
*Assumes $65 million of synergies related to Spartech acquistion
**Assumes no synergies related to Spartech acquistion
Use of Cash
Share DividendsOrganic
G Acquisitions
• Repurchased 1 2
Repurchase
• Introduced a
Dividends
• Expanding our
Growth
T t th t d
Acquisitions
• Repurchased 1.2
million shares in
2012
• 20.0 million
shares are
il bl f
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
available for
repurchase under
the current
authorization
Q1 2013 (20%)
• Objective of
maintaining and
growing
Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
• Synergy opportunities
• Adjacent material solutions
Proforma Cash Balance = $213M
N t D bt / EBITDA* 2 0X
CAPEX
Net Debt / EBITDA* = 2.0X
*Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period
Page 15
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2022-01/Avient Sarl%2C Germany Branch Extract Dec 23 2021.pdf
Handelsregister B des Amtsgerichts Mannheim Nummer der Firma:
Seite 1 von 2
HRB 731450
Nummer
der
Eintragung
a) Firma
b) Sitz, Niederlassung, inländische
Geschäftsanschrift, empfangsberechtigte
Person, Zweigniederlassungen
c) Gegenstand des Unternehmens
Grund- oder
Stammkapital
a) Allgemeine Vertretungsregelung
b) Vorstand, Leitungsorgan, geschäftsführende
Direktoren, persönlich haftende Gesellschafter,
Geschäftsführer, Vertretungsberechtigte und
besondere Vertretungsbefugnis
Prokura a) Rechtsform, Beginn, Satzung oder Gesellschaftsvertrag
b) Sonstige Rechtsverhältnisse
a) Tag der Eintragung
b) Bemerkungen
1 2 3 4 5 6 7
1 a)
PolyOne S.à r.l., Germany Branch
Gaggenau
Geschäftsanschrift:
Adolf-Dambach-Straße 2, 76571 Gaggenau
Zweigniederlassung der "PolyOne S.à r.l."
mit Sitz in Pommerloch / Luxemburg
(Registre de commerce et des sociétés
B226205)
c)
Den Vertrieb und den Großhandel von
Fertigerzeugnissen, die unter anderem aus
ein- und mehrschichtigen
thermoplastischen Platten,
Polymermischungen und Farbkonzentraten
sowie klaren thermogeformten
Kunststoffbehältern bestehen, wobei die
Tätigkeiten für die das Gesetz besondere
Qualifikationen oder Erlaubnisse
vorschreibt, die von der
Zweigniederlassung nicht erfüllt oder
gehalten werden, ausdrücklich
ausgeschlossen sind.
12.000,00
EUR
Jeder Geschäftsführer vertritt einzeln.
Gesellschaft mit beschränkter Haftung nach luxemburgischem
Recht (société à responsibilité limitée)
Gesellschaftsvertrag vom 04.07.2018.
10.09.2018
Kretzler
2 b)
Fielding, Gary J., Chesire / Vereinigtes
Königreich, *20.09.1963
Potoczny, Zaneta Gabriela, Mersch / Luxemburg,
*17.10.1974
Ausgeschieden als
Machin, Geneviéve Elizabeth, Luxemburg /
Luxemburg, *31.03.1972
17.03.2020
Knauf
Abruf vom 27.12.2021 17:13
Handelsregister B des Amtsgerichts Mannheim Nummer der Firma:
Seite 2 von 2
HRB 731450
Nummer
der
Eintragung
a) Firma
b) Sitz, Niederlassung, inländische
Geschäftsanschrift, empfangsberechtigte
Person, Zweigniederlassungen
c) Gegenstand des Unternehmens
Grund- oder
Stammkapital
a) Allgemeine Vertretungsregelung
b) Vorstand, Leitungsorgan, geschäftsführende
Direktoren, persönlich haftende Gesellschafter,
Geschäftsführer, Vertretungsberechtigte und
besondere Vertretungsbefugnis
Prokura a) Rechtsform, Beginn, Satzung oder Gesellschaftsvertrag
b) Sonstige Rechtsverhältnisse
a) Tag der Eintragung
b) Bemerkungen
1 2 3 4 5 6 7
3 a)
Firma geändert; nun:
Avient S.à r.l., Germany Branch
Daten der Hauptniederlassung geändert;
nun:
Zweigniederlassung der "Avient S.à r.l." mit
Sitz in Pommerloch / Luxemburg (Registre
de commerce et des sociétés B226205)
Ausgeschieden als
Fielding, Gary J., Chesire / Vereinigtes
Königreich, *20.09.1963
Merklein, Norbert, Kronberg im Taunus,
*03.05.1964
Der geänderte Gesellschaftsvertrag der Hauptniederlassung
wurde zum Handelsregister eingereicht.
23.12.2021
Georg
Abruf vom 27.12.2021 17:13
https://www.avient.com/sites/default/files/resources/PolyOne%25202018%2520Proxy%2520Statement.PDF
Global CARE Insurance (Critical Care Air Rescue and Evacuation), which provides
supplemental medical services and medical transportation related to business travel, is also provided to all Named
Executive Officers.
2017 Grants of Plan-Based Awards
86,331 (1) 1,151,077 (1) 2,302,154 (1) -
142,500 (2) 1,140,000 (2) 2,280,000 (2) -
2/15/2017 39,400 118,200 (5) 1,419,188
2/15/2017 39,050 (8) 1,331,605
27,769 (1) 370,250 (1) 740,500 (1) -
29,750 (2) 238,000 (2) 476,000 (2) -
2/15/2017 8,217 24,650 (5) 295,964
2/15/2017 8,150 (8) 277,915
15,437 (1) 205,827 (1) 411,654 (1) -
14,000 (2) 112,000 (2) 224,000 (2) -
2/15/2017 3,867 11,600 (5) 139,277
2/15/2017 3,850 (8) 131,285
7/3/2017 10,000 (9) 384,100
16,849 (1) 224,654 (1) 449,308 (1) -
16,000 (2) 128,000 (2) 256,000 (2) -
2/15/2017 4,417 13,250 (5) 159,088
2/15/2017 4,400 (8) 150,040
17,420 (1) 232,269 (1) 464,538 (1) -
16,625 (2) 133,000 (2) 266,000 (2) -
2/15/2017 4,584 13,750 (5) 165,092
2/15/2017 4,550 (8) 155,155
9,329 (1) 124,385 (1) 248,770 (1) -
15,000 (2) 120,000 (2) 240,000 (2) -
15,000 (3) 120,000 (3) 240,000 (3) -
14,500 (3) 116,000 (3) 232,000 (3) -
14,500 (3) 116,000 (3) 232,000 (3) -
2/15/2017 4,150 12,450 (5) 149,483
7/18/2017 4,150 12,450 (6) 181,148
7/18/2017 4,300 12,900 (6) 163,271
7/18/2017 3,300 9,900 (6) 118,041
2/15/2017 4,150 (8) 141,515
7/18/2017 4,182 (10) 161,383
7/18/2017 4,350 (10) 167,867
7/18/2017 3,723 (10) 143,671
9,818 (1) 130,900 (1) 261,800 (1) -
18,000 (2) 144,000 (2) 288,000 (2) -
15,518 (4) 124,141 (4) 248,282 (4) -
8,921 (4) 71,366 (4) 142,732 (4) -
3,199 (4) 25,595 (4) 51,190 (4) -
2/15/2017 4,967 14,900 (5) 178,899
5/31/2017 4,967 14,900 (7) 201,051
5/31/2017 1,737 4,560 (7) 74,765
5/31/2017 3,734 11,200 (7) 131,600
5/31/2017 3,466 3,466 (7) 41,696
2/15/2017 4,950 (8) 168,795
5/31/2017 4,473 (11) 167,022
5/31/2017 2,826 (11) 105,523
5/31/2017 1,180 (11) 44,061
40.19
M.A.
4) Represents a stock-settled RSU award that was granted on July 3, 2017 and generally vests in full on the third
anniversary of the grant date.
Name
Aggregate
Balance at
12/31/2016
($)
Executive
Contributions
in Last FY
($)(2)
Registrant
Contributions
in Last FY
($)(3)
Aggregate
Earnings in
Last FY
($)(4)
Aggregate
Withdrawals/
Distributions
($)
Aggregate
Balance at
Last FYE
($)(1)(5)
R.M.
https://www.avient.com/sites/default/files/2023-03/2023 Avient Bookmarked Proxy Statement - FINAL.pdf
4) Based on 91,071,925 common shares outstanding as of March 1, 2023.
Avient also makes available
executive physicals to all Named Executive Officers (used by all Named Executive Officers).
2022 GRANTS OF PLAN-BASED AWARDS
Grant
Date
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards
Estimated Future Payouts
Under Equity Incentive
Plan Awards
All Other
Awards:
Shares of
or Units
Exercise or
Base Price
of Option
($/Sh)
(i)
Grant Date
Fair Value
of Stock
and Option
(j)
Threshold
Target
Maximum
Threshold
(f)
Target
(g)
— 150,497(1) 1,504,973(1) 3,009,946(1) — — — — —
— 215,000(2) 1,720,000(2) 3,440,000(2) — — — — —
2/14/2022 — — — 44,900(3) 134,700(3) — 52.64 2,006,642
2/14/2022 — — — — — 38,150(4) — 2,008,216
— 42,509(1) 425,086(1) 850,172(1) — — — — —
— 35,625(2) 285,000(2) 570,000(2) — — — — —
2/14/2022 — — — 7,4333) 22,300(3) — 52.64 332,206
2/14/2022 — — — — — 6,350(4) — 334,264
— 31,169(1) 311,688(1) 623,376(1) — — — — —
— 25,500(2) 204,000(2) 408,000(2) — — — — —
2/14/2022 — — — 5,333(3) 16,000(3) — 52.64 238,354
2/14/2022 — — — — — 4,550(4) — 239,512
— 31,641(1) 316,408(1) 632,816(1) — — — — —
— 28,875(2) 231,000(2) 462,000(2) — — — — —
2/14/2022 — — — 6,017(3) 18,050(3) — 52.64 268,893
2/14/2022 — — — — — 5,150(4) — 271,096
— 34,459(1) 344,594(1) 689,188(2) — — — — —
— 25,500(2) 204,000(2) 408,000(2) — — — — —
2/14/2022 — — — 5,333(3) 16,000(3) — 52.64 238,354
2/14/2022 — — — — — 4,550(4) — 239,512
Estimated Future Payouts Under Non-Equity Incentive Plan Awards (columns (c), (d) and (e))
(1) 2022 Annual Incentive Program Opportunities.
Balance at
12/31/2021(1)
Contributions
in Last FY(2)
Registrant
Contributions
in Last FY(3)
Earnings
in Last FY(4)
Withdrawals/
Distributions
Balance at
Last FYE(1)(5)
R.M.
https://www.avient.com/news/avient-attains-acc-responsible-care-14001-global-certification-environmental-health-safety-and-security-excellence
December 4, 2023
CLEVELAND – December 4, 2023 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, proudly announces the successful completion of the Responsible Care® 14001 (RC14001®) certification process, achieving compliance globally across 48 Avient sites.
https://www.avient.com/news/new-non-fluorine-stain-resistant-concentrates-polyester-textiles-avient
February 4, 2025
POMMERLOCH, Luxembourg – February 4, 2025 – Today, Avient Corporation, an innovator of materials solutions, announced the launch of new stain-resistant additive concentrates as the latest addition to its Cesa™ Fiber Additives portfolio.
https://www.avient.com/sites/default/files/2023-09/65799-Certificate-26SEP2023%5B1%5D.pdf
Autopista Medellín KM 2.5 –
Vía Parcelas KM 1, Vereda Sibéria
COTA, Cundinamarca
Colombia
Activity: Manufacture, Laboratory (QC and Colormatching), Sales Activity: Administration, Site management, Manufacture, Laboratory,
Maintenance, Infrastructure, Warehouse and Transport, Sales
Page 4 of 10
Shed No 18–22, GIDC Estate
Panchamahal
Kalol, Gujarat 389330
Facility: P.T.
Avient Colorants Indonesia
Gatot Subroto Km. 4, Jl.
Kalisabi No. 1, Kec.
https://www.avient.com/sites/default/files/2023-02/turkisk-entity-legal-information-en-tu.pdf
İNTERNET SİTESİ İÇERİĞİ
POLYONE TEKNO POLİMER MÜHENDİSLİK PLASTİKLERİ SANAYİ VE TİCARET
ANONİM ŞİRKETİ
Şirket Bilgileri (Yönlendirilmiş Mesaj)
No İçerik Detay
1 Ticaret Unvanı Polyone Tekno Polimer
Mühendislik Plastikleri Sanayi
ve Ticaret Anonim Şirketi
2 MERSİS Numarası 0836003561100014
3 Merkezi Orhan Gazi Mah.1683 Sk.
No.150
Şişli/İstanbul
1
WEBSITE CONTENT
POLYONE TEKNO POLİMER MÜHENDİSLİK PLASTİKLERİ SANAYİ VE TİCARET
ANONİM ŞİRKETİ
Content to be published permanently
* Please note that in case of any changes to the following content, the update shall be
published on the websites on the date such changes occur.
No Content Detail
1 MERSIS number of the Company 0836003561100014
2 Title of the Company Polyone Tekno Polimer
Mühendislik Plastikleri Sanayi
ve Ticaret Anonim Şirketi
3 Registered office of the Company Orhan Gazi Mah.1683 Sk.